Invention Grant
- Patent Title: Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors
-
Application No.: US16468429Application Date: 2016-12-12
-
Publication No.: US10793580B2Publication Date: 2020-10-06
- Inventor: Xifu Liang , Jens Larsen
- Applicant: LEO Pharma A/S
- Applicant Address: DK Ballerup
- Assignee: LEO Pharma A/S
- Current Assignee: LEO Pharma A/S
- Current Assignee Address: DK Ballerup
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- International Application: PCT/EP2016/080550 WO 20161212
- International Announcement: WO2018/108231 WO 20180621
- Main IPC: C07D491/20
- IPC: C07D491/20
Abstract:
The present invention relates to novel pyrazoloazepin-8-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Public/Granted literature
- US20190330223A1 SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Public/Granted day:2019-10-31
Information query
